Patents by Inventor Francesca Romana Fasano
Francesca Romana Fasano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11771102Abstract: The present invention features compositions and methods for modulation of the mucosal immune system. The compositions include foods fermented by the probiotic organism, Lactobacillus paracasei CBA L74 (International Depository Accession Number LMG P-24778). Alternatively the compositions can include L. paracasei CBA L74 and a physiologically acceptable carrier. In some embodiments, the L. paracasei CBA L74 can be non-replicating. The compositions can be administered to a subject having or at risk for gastrointestinal disorders related to immaturity of the immune system, infection or disease.Type: GrantFiled: April 6, 2021Date of Patent: October 3, 2023Assignee: H.J. Heinz Company Brands LLCInventors: Andrea Budelli, Francesca Romana Fasano, Miryam Terzano, Lorenzo Bramati
-
Publication number: 20210259264Abstract: The present invention features compositions and methods for modulation of the mucosal immune system. The compositions include foods fermented by the probiotic organism, Lactobacillus paracasei CBA L74 (International Depository Accession Number LMG P-24778). Alternatively the compositions can include L. paracasei CBA L74 and a physiologically acceptable carrier. In some embodiments, the L. paracasei CBA L74 can be non-replicating. The compositions can be administered to a subject having or at risk for gastrointestinal disorders related to immaturity of the immune system, infection or disease.Type: ApplicationFiled: April 6, 2021Publication date: August 26, 2021Inventors: Andrea Budelli, Francesca Romana Fasano, Miryam Terzano, Lorenzo Bramati
-
Patent number: 10729733Abstract: The present invention features methods for treating or reducing the severity of a microbial infection in an infant of a lactating mother. Compositions comprising food products fermented by Lactobacillus paracasei CBA L74, International Depository Accession Number LMG P-24778 are administered to a pregnant or lactating mother in order to treat or attenuate the severity of a microbial infection in her offspring.Type: GrantFiled: May 25, 2018Date of Patent: August 4, 2020Assignee: H.J. Heinz Company Brands LLCInventors: Francesca Romana Fasano, Maria Rescigno
-
Patent number: 10258656Abstract: The present invention features methods for treating or reducing the severity of a microbial infection in an infant of a lactating mother. Compositions comprising food products fermented by Lactobacillus paracasei CBA L74, International Depository Accession Number LMG P-24778 are administered to a pregnant or lactating mother in order to treat or attenuate the severity of a microbial infection in her offspring.Type: GrantFiled: November 16, 2016Date of Patent: April 16, 2019Assignee: H.J. Heinz Company Brands LLCInventors: Francesca Romana Fasano, Maria Rescigno
-
Patent number: 10251407Abstract: The present application relates to compositions and methods for modulation of the mucosal immune system. The compositions include foods fermented by the probiotic organism, Lactobacillus paracasei CBA L74 (International Depository Accession Number LMG P-24778). Alternatively, the compositions can include L. paracasei CBA L74 and a physiologically acceptable carrier. In some embodiments, the L. paracasei CBA L74 can be non-replicating. The compositions can be administered to a subject having or at risk for gastrointestinal disorders related to immaturity of the immune system, infection or disease.Type: GrantFiled: December 29, 2016Date of Patent: April 9, 2019Assignee: H.J. Heinz Company Brands LLCInventors: Andrea Budelli, Francesca Romana Fasano, Miryam Terzano, Lorenzo Bramati
-
Patent number: 10245300Abstract: The present invention features compositions and methods for treating gluten-related disorders. We describe compositions comprising one or more metabolites produced by Lactobacillus paracasei CBA L74, International Depository Accession Number LMG P-24778 that reduce cellular entry of gliadin peptides. The compositions may include a physiologically acceptable carrier, for example, a food product or a pharmaceutical carrier. The compositions can be administered to a subject having a gluten-related disorder, for example, celiac disease or gluten sensitivity.Type: GrantFiled: June 18, 2013Date of Patent: April 2, 2019Assignee: H.J. Heinz Company Brands LLCInventors: Francesca Romana Fasano, Andrea Luigi Budelli
-
Publication number: 20180271920Abstract: The present invention features methods for treating or reducing the severity of a microbial infection in an infant of a lactating mother. Compositions comprising food products fermented by Lactobacillus paracasei CBA L74, International Depository Accession Number LMG P-24778 are administered to a pregnant or lactating mother in order to treat or attenuate the severity of a microbial infection in her offspring.Type: ApplicationFiled: May 25, 2018Publication date: September 27, 2018Inventors: Francesca Romana Fasano, Maria Rescigno
-
Patent number: 10039296Abstract: The present invention features compositions and methods for modulation of the mucosal immune system. The compositions include foods fermented by the probiotic organism, Lactobacillus paracasei CBA L74 (International Depository Accession Number LMG P-24778). Alternatively the compositions can include L. paracasei CBA L74 and a physiologically acceptable carrier. In some embodiments, the L. paracasei CBA L74 can be non-replicating. The compositions can be administered to a subject having or at risk for gastrointestinal disorders related to immaturity of the immune system, infection or disease.Type: GrantFiled: June 18, 2012Date of Patent: August 7, 2018Assignee: H.J. Heinz Company Brands LLCInventors: Andrea Budelli, Francesca Romana Fasano, Miryam Terzano, Lorenzo Bramati
-
Patent number: 9980991Abstract: The present invention features methods for treating or reducing the severity of a microbial infection in an infant of a lactating mother. Compositions comprising food products fermented by Lactobacillus paracasei CBA L74, International Depository Accession Number LMG P-24778 are administered to a pregnant or lactating mother in order to treat or attenuate the severity of a microbial infection in her offspring.Type: GrantFiled: May 9, 2014Date of Patent: May 29, 2018Assignee: H.J. Heinz Company Brands LLCInventors: Francesca Romana Fasano, Maria Rescigno
-
Publication number: 20170202231Abstract: The present application relates to compositions and methods for modulation of the mucosal immune system. The compositions include foods fermented by the probiotic organism, Lactobacillus paracasei CBA L74 (International Depository Accession Number LMG P-24778). Alternatively, the compositions can include L. paracasei CBA L74 and a physiologically acceptable carrier. In some embodiments, the L. paracasei CBA L74 can be non-replicating. The compositions can be administered to a subject having or at risk for gastrointestinal disorders related to immaturity of the immune system, infection or disease.Type: ApplicationFiled: December 29, 2016Publication date: July 20, 2017Inventors: Andrea Budelli, Francesca Romana Fasano, Miryam Terzano, Lorenzo Bramati
-
Publication number: 20170065648Abstract: The present invention features methods for treating or reducing the severity of a microbial infection in an infant of a lactating mother. Compositions comprising food products fermented by Lactobacillus paracasei CBA L74, International Depository Accession Number LMG P-24778 are administered to a pregnant or lactating mother in order to treat or attenuate the severity of a microbial infection in her offspring.Type: ApplicationFiled: November 16, 2016Publication date: March 9, 2017Inventors: Francesca Romana Fasano, Maria Rescigno
-
Publication number: 20160113973Abstract: The present invention features methods for treating or reducing the severity of a microbial infection in an infant of a lactating mother. Compositions comprising food products fermented by Lactobacillus paracasei CBA L74, International Depository Accession Number LMG P-24778 are administered to a pregnant or lactating mother in order to treat or attenuate the severity of a microbial infection in her offspring.Type: ApplicationFiled: May 9, 2014Publication date: April 28, 2016Inventors: Francesca Romana Fasano, Maria Rescigno
-
Publication number: 20150174199Abstract: The present invention features compositions and methods for treating gluten-related disorders. We describe compositions comprising one or more metabolites produced by Lactobacillus paracasei CBA L74, International Depository Accession Number LMG P-24778 that reduce cellular entry of gliadin peptides. The compositions may include a physiologically acceptable carrier, for example, a food product or a pharmaceutical carrier. The compositions can be administered to a subject having a gluten-related disorder, for example, celiac disease or gluten sensitivity.Type: ApplicationFiled: June 18, 2013Publication date: June 25, 2015Applicant: H.J. HEINZ COMPANYInventors: Francesca Romana Fasano, Andrea Luigi Budelli
-
Publication number: 20140377238Abstract: The present invention features compositions and methods for modulation of the mucosal immune system. The compositions include foods fermented by the probiotic organism, Lactobacillus paracasei CBA L74 (International Depository Accession Number LMG P-24778). Alternatively the compositions can include L. paracasei CBA L74 and a physiologically acceptable carrier. In some embodiments, the L. paracasei CBA L74 can be non-replicating. The compositions can be administered to a subject having or at risk for gastrointestinal disorders related to immaturity of the immune system, infection or disease.Type: ApplicationFiled: June 18, 2012Publication date: December 25, 2014Applicant: H.J. Heinz CompanyInventors: Andrea Budelli, Francesca Romana Fasano, Miryam Terzano, Lorenzo Bramati